Leukemia drug shows the potential to treat aggressive pediatric brain câncer

(Fundação de Amparo Pesquisa do Estado de São Paulo) When tested in vitro, arsenic trioxide killed tumor cells and prevented the formation of new colonies. This leukemia drug also boosted the effect of radiation therapy on medulloblastoma, a type of central nervous system tumor most common in children.